U.S. Residential REITs Stock News

In the past week, Gibraltar Industries, Inc. reported second-quarter 2026 results showing sales rising to US$509.55 million from US$309.52 million a year earlier, while net income fell to US$8.19 million from US$26 million and earnings per share weakened on both a quarterly and year-to-date basis. At the same time, the company reiterated its full-year 2026 guidance, projecting consolidated net sales of US$1.76 billion to US$1.83 billion and GAAP diluted EPS of US$2.40 to US$2.80,...

In late July 2026, Bandwidth Inc. reported second‑quarter 2026 results showing year‑over‑year sales growth to US$219.9 million and a move to US$2.39 million in net income, raised full‑year 2026 revenue guidance to US$900 million–US$910 million, amended its credit agreement to increase permitted restricted payments, continued share repurchases, and announced the planned year‑end retirement of General Counsel and Secretary R. Brandon Asbill. A key insight is that Bandwidth is pairing improved...

Commerce.com (CMRC) is back in focus after a mixed set of August 6 updates. The company reported a return to quarterly profitability, announced fresh client partnerships, and at the same time lowered its full year 2026 revenue guidance. See our latest analysis for Commerce.com. Commerce.com’s share price has fallen 29.1% over the past week and is down 45.3% year to date, while the 1-year total shareholder return has declined 49.1%. This suggests that recent earnings progress has not yet eased...

Integra LifeSciences Holdings Corporation reported past second-quarter 2026 results showing sales of US$418.76 million and net income of US$4.48 million, a shift from a large net loss a year earlier. The company also modestly reduced its full-year 2026 reported revenue outlook due to currency headwinds while reaffirming its organic revenue growth and adjusted EPS guidance, underscoring the effect of foreign exchange on reported performance. We’ll now examine how this earnings improvement,...

FB Financial stock has delivered a strong 86.8% return over the past three years, while the latest Excess Returns intrinsic value estimate suggests the shares trade at a discount to fair value even though broader valuation checks lean cautious. That mix leaves investors weighing a stock that has already performed well against signals that it may still be pricing in a margin of safety. FB Financial's 86.8% return over three years points to a stock that has already rewarded shareholders and...

Helmerich & Payne (HP) drew fresh attention after reporting fiscal Q3 2026 results that came in above its own guidance, along with a higher full-year North America rig-count outlook and a continued focus on debt reduction. See our latest analysis for Helmerich & Payne. At a share price of $37.10, Helmerich & Payne has seen a 30 day share price return of 11.31% and a year to date share price return of 23.91%, while the 1 year total shareholder return of 122.62% contrasts with a modest 3 year...

AtriCure (ATRC) has drawn investor attention after multiple insider share sales. This followed a quarter in which the company reported 13% second quarter revenue growth, a return to net income, and raised full year guidance. See our latest analysis for AtriCure. AtriCure’s recent insider sales come against a backdrop of strong share price momentum, with a 57.38% 90 day share price return and 20.74% 30 day share price return, while the 5 year total shareholder return is still down 43.49%. If...

Pediatrix Medical Group has delivered a strong 89.0% share price return over the past year, yet the stock still screens as cheap on several valuation checks. This raises the question of how much of the recent improvement is already reflected in the price. The recent share price drop following earnings news adds another layer for investors weighing whether the current level still offers value. Over the last 1 year, Pediatrix Medical Group shares are up 89.0%. This means anyone looking at the...

What the latest earnings mean for Organogenesis Holdings stock Organogenesis Holdings (ORGO) is back in focus after second quarter results showed sharply lower revenue and a much wider net loss, alongside a deeper revenue outlook cut and a planned US$75 million equity raise. The earnings update matters for you because it reshapes expectations on cash generation, dilution risk and how much flexibility Organogenesis Holdings might have to fund its wound care portfolio, including products like...

Weaker US job numbers, softer wage growth, and fading odds of a September Fed hike have put major bank stocks under a sharper spotlight. When the labor market cools and rate expectations shift, the ripple effects can matter for profits, loan quality, and investor confidence. This article walks through three large US bank stocks that appear especially exposed to this latest data, and explains why that may give you a reason to reassess your own banking exposure today. Wells Fargo...

Insight Enterprises stock has gained 77.8% year to date, and current valuation checks suggest the market price still sits below an intrinsic value estimate based on a Discounted Cash Flow (DCF), with earnings multiples telling a similar story. Year to date, Insight Enterprises is up 77.8%, which puts extra focus on whether recent gains already reflect the company’s long term cash flow potential. Future revenue and cash flow growth can support the current share price, while any pressure on...

Adams Diversified Equity Fund, Inc. has reported past-half‑year earnings for the period ended June 30, 2026, posting revenue of US$18.94 million and net income of US$320.68 million. The large gap between revenue and net income draws attention to how factors beyond core fee income may have influenced overall profitability. We will now explore how the strong net income reported for the half year shapes Adams Diversified Equity Fund’s investment narrative. Uncover the next big thing with 20...

Bowhead Specialty Holdings earnings and buyout agreement set the scene Bowhead Specialty Holdings (BOW) just reported second quarter 2026 results, alongside news that American Family Mutual Insurance Company agreed to acquire the remaining 84.8% stake for US$34.00 per share in cash. See our latest analysis for Bowhead Specialty Holdings. Bowhead Specialty Holdings’ share price has moved to US$33.45, with a 7 day share price return of 9.35% and a 90 day share price return of 20.02%. The 1 year...

TIC Solutions (TIC) drew fresh attention on 6 August 2026 after reaffirming full year revenue guidance of US$2,150 million to US$2,250 million and reporting second quarter results that combined higher sales with continued net losses. See our latest analysis for TIC Solutions. The reaffirmed guidance and second quarter update appear to have sharpened investor focus on TIC Solutions, with a 1 day share price return of 15.9% and a 7 day share price return of 37.6% lifting the share price to...

Regulators are turning up the heat on false discounts, subscription traps and opaque pricing, and that puts a fresh spotlight on companies that help retailers stay on the right side of consumer protection rules. This shift creates potential winners among compliance and retail technology specialists, as demand for transparent pricing and subscription management tools grows. This article reveals 3 stocks tied to these changes and explains how the news connects to each one. The three stocks in...

In late July 2026, Expand Energy Corporation reported second-quarter results showing revenue of US$2,960 million and net income of US$522 million, alongside higher production of 7,482 MMcfe per day and confirmation of its quarterly US$0.575 per-share dividend. Despite lower quarterly earnings than a year earlier, the company increased year-to-date revenue and net income, reaffirmed its 2026 production targets, and completed a significant share repurchase program totaling 10,026,164 shares...

China’s latest inflation data points to softer domestic demand and weaker producer pricing power. That often pushes investors toward companies with strong balance sheets, resilient cash generation and high return on equity. These businesses can sometimes hold their ground when pricing power is under pressure. This article highlights 3 stocks from our Solid Balance Sheet and Fundamentals screener that fit that profile and may deserve a closer look now. The stocks covered below are just a...

Plexus guidance and buyback put fresh focus on PLXS stock Plexus (PLXS) has drawn investor attention after issuing new earnings guidance alongside its third quarter results and an update on its ongoing share repurchase program. The company now expects fourth quarter revenue between US$1.33b and US$1.38b, with GAAP diluted EPS in a range of US$2.18 to US$2.34 and operating margin of 5.5% to 5.9%. See our latest analysis for Plexus. Plexus shares have recently picked up momentum, with a 7-day...

With the labor market stuck in low gear, inflation data looming and interest rates staying higher for longer, big US financial stocks sit right in the crosshairs of the latest macro story. That mix can reward resilience and punish fragility, which is why investors watching this sector closely do not want to look away now. This article walks through 3 large US financial stocks exposed to these forces and explains what stands out. The stocks covered below are just a starting sample, and the...

In late July 2026, Hubbell Incorporated reported second-quarter results showing sales of US$1,711.8 million with stable earnings per share alongside higher year-to-date profit, and issued full-year 2026 guidance calling for total sales growth of 16–18% including 9–11% organic growth, with GAAP diluted EPS expected between US$17.25 and US$17.55. An interesting takeaway is that Hubbell’s strong top-line momentum is not yet fully translating into higher quarterly earnings, as net income dipped...

Securitize stock has fallen around 31.5% year to date, yet on broad valuation checks it still screens as expensive rather than obviously cheap after that pullback. Year to date, Securitize is down about 31.5%, which raises the question of whether recent weakness has fully reset expectations or if investors are still paying up for the story. Future revenue and cash flow expectations can support the current share price if they are met. However, any pressure on profitability or funding costs...

Global Net Lease has delivered a 31.1% return over the past year, and the key question for investors now is how that share price move lines up with what the valuation work is saying about the stock. Global Net Lease is up 31.1% over the past year, which puts more focus on whether the current price still leaves enough room against its underlying fundamentals. Improving balance sheet metrics and plans to reshape the property portfolio can support future cash flows. At the same time, execution...

Relay Therapeutics earnings update and what it might mean for the stock Relay Therapeutics (RLAY) reported second quarter 2026 results today, with lower revenue and a wider net loss compared with a year earlier. These figures provide a fresh snapshot of the company’s progress and cash burn. See our latest analysis for Relay Therapeutics. Relay Therapeutics shares have pulled back slightly over the past month, with a 30 day share price return of 1.17% lower. However, momentum has been strong...

Webster Financial (WBS) is back in focus after its board declared a quarterly common dividend of $0.40 per share, alongside second quarter 2026 earnings per share of $1.56 and adjusted EPS of $1.60. See our latest analysis for Webster Financial. The quarterly dividend and solid Q2 EPS have arrived after a strong run for Webster Financial, with the share price at $79.03 and a year to date share price return of 23.83%, while the 1 year total shareholder return of 45.11% and 3 year total...